In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 8th, 2009 | 48 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -1.40 | 8.04 | -139.2 | 5 | 17 | -2 | 263 | 680.756 | 20 | ↓ |
Lo Low (pH 4.5-6) | -1.40 | 6.51 | -67.12 | 6 | 17 | -1 | 260 | 681.764 | 20 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CATB-1-E | Cathepsin B (cluster #1 Of 6), Eukaryotic | Eukaryotes | 9500 | 0.15 | Binding ≤ 10μM |
CEL2A-2-E | Elastase 2A (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2200 | 0.17 | Binding ≤ 10μM |
CELA1-1-E | Elastase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.17 | Binding ≤ 10μM |
ELNE-2-E | Neutrophil Elastase (cluster #2 Of 3), Eukaryotic | Eukaryotes | 6700 | 0.15 | Binding ≤ 10μM |
A3EZI9-2-V | Hepatitis C Virus NS3 Protease/helicase (cluster #2 Of 3), Viral | Viruses | 1100 | 0.17 | Binding ≤ 10μM |
D2K2A8-1-V | Hepatitis C Virus NS4A Protein (cluster #1 Of 1), Viral | Viruses | 1100 | 0.17 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CATB_HUMAN | P07858 | Cathepsin B, Human | 9500 | 0.15 | Binding ≤ 10μM |
CELA1_PIG | P00772 | Elastase 1, Pig | 2200 | 0.17 | Binding ≤ 10μM |
CEL2A_PIG | P08419 | Elastase 2A, Pig | 2200 | 0.17 | Binding ≤ 10μM |
A3EZI9_9HEPC | A3EZI9 | Hepatitis C Virus NS3 Protease/helicase, 9hepc | 1100 | 0.17 | Binding ≤ 10μM |
D2K2A8_9HEPC | D2K2A8 | Hepatitis C Virus NS4A Protein, 9hepc | 1100 | 0.17 | Binding ≤ 10μM |
ELNE_HUMAN | P08246 | Leukocyte Elastase, Human | 6700 | 0.15 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of Matrix Metalloproteinases | |
Assembly of collagen fibrils and other multimeric structures | |
Collagen degradation | |
Degradation of the extracellular matrix | |
MHC class II antigen presentation | |
Trafficking and processing of endosomal TLR |